Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | The management of chlormethine gel-induced dermatitis

Marios Koumourtzis • 14 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases Chlormethine

Marios Koumourtzis, MD, University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece, outlines the management of chlormethine gel-induced dermatitis in patients with cutaneous T-cell lymphoma (CTCL). Dr Koumourtzis reports that patients should continue using chlormethine gel if they develop dermatitis, suggesting a reduction in the frequency of application. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Marios Koumourtzis

2:49
Highlighting unmet needs for CTCL
Evangelina Papadavid et al. • 15 Oct 2021
1:03
Real-world data on chlormethine gel for mycosis fungoides
Marios Koumourtzis • 14 Oct 2021
1:07
Positioning chlormethine gel for the treatment of mycosis fungoides
Marios Koumourtzis • 14 Oct 2021

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals